Explore 6 articles related to opioid use disorder.
Louisiana faces one of the nation's most severe opioid epidemics, with overdose death rates far exceeding national averages. This comprehensive guide examines the crisis, fentanyl's role, and evidence-based treatment approaches available to Louisiana residents.
Naltrexone offers a non-agonist, non-addictive MAT option for opioid use disorder that is free from diversion risk. This guide covers the clinical evidence, detox prerequisites, patient selection, and how naltrexone compares to buprenorphine and methadone for OUD treatment.
A comprehensive clinical guide to methadone maintenance treatment (MMT) for opioid addiction, covering federal regulations, dosing protocols, take-home policies, comparing methadone to buprenorphine and naltrexone, and accessing programs in Orange County, California.
A clinically grounded comparison of oral naltrexone (ReVia) and extended-release injectable naltrexone (Vivitrol), covering pharmacology, adherence data, cost considerations, and which formulation best supports long-term recovery.
An evidence-based clinical guide to Suboxone (buprenorphine/naloxone) treatment for opioid use disorder, covering induction protocols, maintenance therapy, side effects, and long-term recovery outcomes supported by SAMHSA and FDA guidelines.
Endorphins are the brain's natural opioids, released in response to pain, exercise, and social bonding to promote survival and wellbeing. Understanding how opioid drugs mimic and ultimately suppress this system reveals why opioid use disorder is both biologically powerful and clinically treatable.
Recovery begins with a single step. Our compassionate team is here to guide you every step of the way.